alpha-aminopyridine has been researched along with Lung Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Page, C; Stolfa, I | 1 |
| Abraham, J; Budd, GT; Dalpiaz, N; Jazieh, KA | 1 |
| Berra, G; Gianella, P; Glatz, N; Janssens, JP | 1 |
| Chan, HC; Chen, J; Chen, Y; Dong, ZW; Peng, YZ; Ruan, YC; Tsang, LL; Zhou, T | 1 |
| Gillissen, A; Häussermann, A | 1 |
| Bleyer, M; Braun, A; Fieguth, HG; Förster, C; Fuchs, E; Hohlfeld, JM; Kaup, FJ; Knauf, S; Lauenstein, HD; Neuhaus, V; Pfennig, O; Schlumbohm, C; Seehase, S; Sewald, K; Switalla, S | 1 |
| Dai, YR; Xia, XD; Xu, ZJ | 1 |
| Doggrell, SA | 1 |
3 review(s) available for alpha-aminopyridine and Lung Diseases
| Article | Year |
|---|---|
[New therapeutic options in pulmonary diseases in 2016 : focus on asthma, COPD and idiopathic pulmonary fibrosis (IPF)].
Topics: Aminopyridines; Asthma; Benzamides; Cyclopropanes; Humans; Idiopathic Pulmonary Fibrosis; Lung Diseases; Pulmonary Disease, Chronic Obstructive; Pulmonary Medicine; Therapies, Investigational | 2017 |
[Diseases of the lung and air passages 2010].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aminopyridines; Asthma; Benzamides; Cyclopropanes; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Indans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Phosphodiesterase 4 Inhibitors; Pneumonia, Bacterial; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones | 2010 |
[Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Asthma; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Lung Diseases; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyridines | 2004 |
5 other study(ies) available for alpha-aminopyridine and Lung Diseases
| Article | Year |
|---|---|
Phosphodiesterase inhibitors and lung diseases.
Topics: Aminopyridines; Humans; Lung Diseases; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive | 2023 |
Can CDK4/6 inhibitors cause fatal lung injury?
Topics: Aminopyridines; Antineoplastic Agents; Benzimidazoles; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Humans; Lung Diseases; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines | 2019 |
CFTR-regulated MAPK/NF-κB signaling in pulmonary inflammation in thermal inhalation injury.
Topics: Aminopyridines; Animals; Benzodioxoles; Cell Line; Curcumin; Cyclooxygenase 2; Cystic Fibrosis Transmembrane Conductance Regulator; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Hot Temperature; Inflammation; Inhalation; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Lung Diseases; Male; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; NF-kappa B; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2015 |
LPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testing.
Topics: Aged; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveolar Lavage Fluid; Callithrix; Cyclopropanes; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Immunosuppressive Agents; Inflammation; Inflammation Mediators; Lipopolysaccharides; Lung; Lung Diseases; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Tumor Necrosis Factor-alpha | 2012 |
Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Aminopyridines; Anti-Inflammatory Agents; Asthma; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Humans; Lung Diseases; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Ventilation; Randomized Controlled Trials as Topic | 2006 |